Emerald Health Therapeutics financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2013 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
C$0.00M | C$0.03M | C$0.25M | C$0.94M | C$1.95M | C$20.32M | C$11.74M | C$9.68M | C$0.00M | C$0.00M | C$0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | -138.14% | -30.45% | -13.87% | -53.10% | -78.21% | -66.66% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -251.05% | -229.95% | -214.20% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
C$0.00 | ||||||||||
| Div. | Dividends |
|
C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
46.07m | 46.07m | 67.66m | 105.57m | 141.44m | 160.99m | 206.36m | 213.32m | 0m | 213.47m | 0m |
| OCF | Operating Cash Flow |
|
C$-1.25M | C$-2.25M | C$-2.05M | C$-7.82M | C$-29.09M | C$-24.77M | C$-10.50M | C$-17.11M | C$-0.01M | C$0.00M | C$0.00M |
| FCF | Free Cash Flow |
|
C$-1.47M | C$-2.56M | C$-2.29M | C$-10.07M | C$-46.32M | C$-48.85M | C$-13.51M | C$-18.02M | C$-0.02M | C$0.00M | C$0.00M |
| FCFS | Free Cash Flow Per Share |
|
C$-0.04 | C$-0.06 | C$-0.04 | C$-0.11 | C$-0.34 | C$-0.34 | C$-0.07 | C$-0.09 | C$0.00 | C$0.00 | C$0.00 |